CrystalGenomics Inc (08790) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

CrystalGenomics Inc (CrystalGenomics) is a biopharmaceutical company that discovers and develops drugs based on structural chemoproteomics. The companys lead development candidate include NSAID, which is a tissue specific anti-inflammatory agent with osteoarthritis, cardiovascular, gastrointestinal, and renal safety profiles. Its drug candidates comprise CG200745, a histone deacetylase inhibitor for cancer; and CG400549, an antibiotic candidate for methicillin resistant staphylococcus aureus and vancomycin resistant staphylococcus aureus. CrystalGenomics offers cloning, expression, purification, and characterization of proteins of interest; and assay and structure services. The companys technologies include soluble protein solution, structural chemo proteomics, and structural-based drug factory. CrystalGenomics is headquartered in Seongnam, South Korea.

CrystalGenomics Inc (08790) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

List of Tables 4
List of Figures 4
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CrystalGenomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CrystalGenomics Enters into Agreement with Dong-A ST for Acelex 10
CrystalGenomics Enters into Co-Marketing Agreement with Daewoong Pharma 11
SAFC Pharma Enters Into Co-Development Agreement With CrystalGenomics 12
Licensing Agreements 1
Aptose Biosciences Enters into Licensing Agreement with CrystalGenomics 1
TR-Pharm Enters into Licensing Agreement with CrystalGenomics 14
Equity Offering 15
CrystalGenomics to Raise USD0.8 Million in Private Placement of Shares 15
CrystalGenomics Raises USD12.7 Million in Private Placement of Shares 16
CrystalGenomics Completes Private Placement Of Shares For US$2.6 Million 17
Acquisition 18
CrystalGenomics Acquires Hwail Pharma 18
CrystalGenomics Inc - Key Competitors 19
CrystalGenomics Inc - Key Employees 20
CrystalGenomics Inc - Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Product News 22
04/19/2017: Aptose Biosciences To Present CG-806 Data At AACR Hematologic Malignancies Meeting 22
01/2/2017: Aptose Prioritizes Development of CG806 First-in Class FLT/BTK Inhibitor 2
Clinical Trials 24
Sep 12, 2017: Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG806 24
May 08, 2017: OHSU and Aptose Present CG806 Preclinical Data Demonstrating Potent Activity Against Patient Samples at AACR Hematologic Malignancies Meeting 25
May 08, 2017: Preclinical Data on Aptose Biosciences FLT/BTK Inhibitor CG806 Presented at AACR Hematologic Malignancies Meeting 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List Of Tables

List of Tables
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CrystalGenomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CrystalGenomics Inc, Deals By Therapy Area, 2012 to YTD 2018 8
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CrystalGenomics Enters into Agreement with Dong-A ST for Acelex 10
CrystalGenomics Enters into Co-Marketing Agreement with Daewoong Pharma 11
SAFC Pharma Enters Into Co-Development Agreement With CrystalGenomics 12
Aptose Biosciences Enters into Licensing Agreement with CrystalGenomics 13
TR-Pharm Enters into Licensing Agreement with CrystalGenomics 14
CrystalGenomics to Raise USD0.8 Million in Private Placement of Shares 15
CrystalGenomics Raises USD12.7 Million in Private Placement of Shares 16
CrystalGenomics Completes Private Placement Of Shares For US$2.6 Million 17
CrystalGenomics Acquires Hwail Pharma 18
CrystalGenomics Inc, Key Competitors 19
CrystalGenomics Inc, Key Employees 20
CrystalGenomics Inc, Subsidiaries 21

List Of Figures

List of Figures
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
CrystalGenomics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8